ALS

Muscular Dystrophy Association's ALS Fundraiser Lights up Hope for Patients

Læs om hvordan MDA gør en forskel for ALS-patienter og deres pårørende! 💪

Muscular Dystrophy Association's Annual ALS Fundraiser "Night of..." showcases the incredible work done by the organization in advancing research, care, and advocacy for individuals battling muscular dystrophy, ALS, and related neuromuscular diseases. Their commitment to improving the lives of those affected shines bright at this annual fundraising event, bringing hope and support to patients and their families.

BrainStorm Cell Therapeutics is forging ahead with their innovative NurOwn stem cell therapy for ALS, despite setbacks. The company faced challenges after withdrawing its BLA due to data discrepancies highlighted by an FDA advisory committee. However, their perseverance and dedication to finding a breakthrough treatment for ALS patients continue to drive them forward.

Fun Fact: Did you know that MDA is the #1 health nonprofit supporting research and care for individuals with muscular dystrophy, ALS, and related neuromuscular diseases? Their impact in the medical field is unparalleled, striving to improve the quality of life for those in need.

Interesting Fact: BrainStorm Cell Therapeutics' NurOwn therapy holds immense potential in revolutionizing ALS treatment. With continued efforts and advancements, this innovative approach could potentially change the landscape of ALS care and provide hope for countless patients.